Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics from Client Faraday Future
Pooled Safety Analysis of Enobosarm from Phase 2 and Phase 3 Placebo-Controlled Clinical Trials Date: Saturday, June 22, 2024…
						
				
				
				
				
				
				
				
				
				
				



